Trials in Esophageal Ca, HCC Fall Short

See on Scoop.itMyHealthShare Medical Reporter

SAN FRANCISCO — Patients with esophageal cancer derived no survival benefit with the addition of cetuximab to chemoradiation, while everolimus fared no better in a trial of patients with hepatocellul…

MyHealthShare‘s insight:

Trials in Esophageal Ca, HCC Fall Short | @scoopit http://sco.lt/…http://myhealthshare @medpagetoday @cbankheadmpt #cancer #esophageal

See on www.medpagetoday.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s